-
From the Editor-in-Chief
DNA Profiling Moves From Forensics to DiagnosticsDNA profiling technologies are providing new ways to detect and monitor cancer.
by William G. Nelson, MD, PhD
-
Forward Look
Banking on BacteriaResponse to immunotherapy may be linked to gut microbiome.
by Chris Palmer
-
Forward Look
Improving Cancer Care in Sub-Saharan AfricaNew guidelines account for limited medical resources.
by Cameron Walker
-
Forward Look
Treating Early-Stage Lung CancerEfforts are underway to define role of high-dose radiation.
by Stephen Ornes
-
Healthy Habits
Head StartDeveloping healthy behaviors in young adulthood can help reduce cancer risk later in life.
by Brenda Conaway
-
Searching Blood for Cancer Clues
Researchers are developing blood tests that help track and identify molecular changes in tumors. But many hurdles remain before these “liquid biopsies” become standard.
by Stephen Ornes
-
Liver Cancer on the Rise
Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.
by Sue Rochman
-
Gaps in End-of-Life Care
Racial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.
by Charlotte Huff
-
Online Discussions Reveal Little-Known Side Effects
Analyzing online patient conversations could shed light on adverse drug reactions.
by Brad Jones
-
Is 3-D Mammography Better?
A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.
by Marci A. Landsmann
Cancer Talk
Musical Toxicity an Effect of Cancer Treatment
Study finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert